Modelling thymic HIV-1 nef effects

Current HIV Research

Volumn 4, Issue 1, 2006, Pages 57-64

  Stove, Veronique ^a   Verhasselt, Bruno ^a  

^a GHENT UNIVERSITY   (Belgium)

Author keywords

HIV 1; Nef; Thymopoiesis

Indexed keywords

ADENOSINE DIPHOSPHATE RIBOSYLATION FACTOR 6; APOPTOSIS SIGNAL REGULATING KINASE 1; CD1D ANTIGEN; CD2 ANTIGEN; CD28 ANTIGEN; CD3 ANTIGEN; CD4 ANTIGEN; CHEMOKINE RECEPTOR CCR5; CHEMOKINE RECEPTOR CXCR4; CYCLIN T1; FAS LIGAND; HEMATOPOIETIC CELL KINASE; HLA A ANTIGEN; HLA B ANTIGEN; HLA C ANTIGEN; HLA E ANTIGEN; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1; MITOGEN ACTIVATED PROTEIN KINASE; NEF PROTEIN; PHOSPHATIDYLINOSITOL 3 KINASE; PROTEIN BCL 2; PROTEIN KINASE FYN; PROTEIN KINASE LCK; PROTEIN KINASE LYN; PROTEIN P53; STRESS ACTIVATED PROTEIN KINASE; T LYMPHOCYTE RECEPTOR BETA CHAIN; T6 ANTIGEN; TRANSACTIVATOR PROTEIN; TUMOR NECROSIS FACTOR ALPHA;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; APOPTOSIS; DOWN REGULATION; GENE EXPRESSION REGULATION; GENETIC CONSERVATION; GENETIC TRANSCRIPTION; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNE DEFICIENCY; NONHUMAN; OPEN READING FRAME; PROTEIN FUNCTION; PROTEIN PHOSPHORYLATION; PROTEIN PROTEIN INTERACTION; REVIEW; SIGNAL TRANSDUCTION; T LYMPHOCYTE ACTIVATION; THYMUS; VIRAL GENETICS; VIRUS INFECTIVITY; VIRUS PATHOGENESIS; VIRUS VIRULENCE; ANIMAL; CYTOLOGY; DISEASE MODEL; GENETICS; IMMUNOLOGY; METABOLISM; MOUSE; MOUSE MUTANT; PATHOGENICITY; PATHOPHYSIOLOGY; REGULATOR GENE; TRANSGENIC ANIMAL; VIROLOGY;

ANIMALS; ANIMALS, GENETICALLY MODIFIED; DISEASE MODELS, ANIMAL; GENE PRODUCTS, NEF; GENES, NEF; HIV INFECTIONS; HIV-1; HUMANS; MICE; MICE, SCID; THYMUS GLAND;

EID: 33644926146     PISSN: 1570162X     EISSN: None     Source Type: Journal    
DOI: 10.2174/157016206775197583     Document Type: Review

References (83)

1. Aiken C, Konner J, Landau NR, Lenburg ME, Trono D. (1994). Nef induces CD4 endocytosis: requirement for a critical dileucine motif in the membrane-proximal CD4 cytoplasmic domain. Cell. 76: 853-864.
2. Aldrovandi GM, Feuer G, Gao L, Jamieson B, Kristeva M, Chen IS, Zack JA. (1993). The SCID-hu mouse as a model for HIV-1 infection. Nature. 363: 732-736.
3. Aldrovandi GM, Gao L, Bristol G, Zack JA. (1998). Regions of human immunodeficiency virus type 1 nef required for function in vivo. Journal of Virology. 72: 7032-7039.
4. Aldrovandi GM, Zack JA. (1996). Replication and pathogenicity of human immunodeficiency virus type 1 accessory gene mutants in SCID-hu mice. Journal of Virology. 70: 1505-1511.
5. Arora VK, Fredericksen BL, Garcia JV. (2002). Nef: agent of cell subversion. Microbes and Infection. 4: 189-199.
6. Bieniasz PD, Grdina TA, Bogerd HP, Cullen BR. (1998). Recruitment of a protein complex containing Tat and cyclin T1 to TAR governs the species specificity of HIV-1 Tat. The EMBO Journal. 17: 7056-7065.
7. Blagoveshchenskaya AD, Thomas L, Feliciangeli SF, Hung CH, Thomas G. (2002). HIV-1 Nef downregulates MHC-I by a PACS-1- and P13K-regulated ARF6 endocytic pathway. Cell. 111: 853-866.
8. Bonyhadi ML, Rabin L, Salimi S, Brown DA, Kosek J, McCune JM, Kaneshima H. (1993). HIV induces thymus depletion in vivo. Nature. 363: 728-732.
9. Brady HJ, Pennington DJ, Miles CG, Dzierzak EA. (1993). CD4 cell surface downregulation in HIV-1 Nef transgenic mice is a consequence of intracellular sequestration. The EMBO Journal. 12: 4923-4932.
10. Cho S, Knox KS, Kohli LM, He JJ, Exley MA, Wilson SB, Brutkiewicz RR. (2005). Impaired cell surface expression of human CD1d by the formation of an HIV-1 Nef/CD1d complex. Virology. 337: 242-252.
11. Cohen GB, Gandhi RT, Davis DM, Mandelboim O, Chen BK, Strominger JL, Baltimore D. (1999). The selective downregulation of class I major histocompatibility complex proteins by HIV-1 protects HIV-infected cells from NK cells. Immunity. 10: 661-671.
12. De SK, Marsh JW. (1994). HIV-1 Nef inhibits a common activation pathway in NIH-3T3 cells. Journal of Biological Chemistry. 269: 6656-6660.
13. Deacon NJ, Tsykin A, Solomon A, Smith K, Ludford Menting M, Hooker DJ, McPhee DA, Greenway AL, Ellett A, Chatfield C, Lawson VA, Maerz A, Crowe S, Sonza S, Learmont J, Sullivan JS, Cunningham A, Dwyer D, Dowton D, Mills J. (1995). Genomic structure of an attenuated quasi species of HIV-1 from a blood transfusion donor and recipients. Science. 270: 988-991.
14. Dickie P, Ramsdell F, Notkins AL, Venkatesan S. (1993). Spontaneous and inducible epidermal hyperplasia in transgenic mice expressing HIV-1 Nef. Virology. 197: 431-438.
15. Dion ML, Poulin JF, Bordi R, Sylvestre M, Corsini R, Kettaf N, Dalloul A, Boulassel MR, Debre P, Routy JP, Grossman Z, Sekaly RP, Cheynier R. (2004). HIV infection rapidly induces and maintains a substantial suppression of thymocyte proliferation. Immunity. 21: 757-768.
16. Douek DC, Betts MR, Hill BJ, Little SJ, Lempicki R, Metcalf JA, Casazza J, Yoder C, Adelsberger JW, Stevens RA, Baseler MW, Keiser P, Richman DD, Davey RT, Koup RA. (2001). Evidence for increased T cell turnover and decreased thymic output in HIV infection. Journal of Immunology. 167: 6663-6668.
17. Douek DC, McFarland RD, Keiser PH, Gage EA, Massey JM, Haynes BF, Polis MA, Haase AT, Feinberg MB, Sullivan JL, Jamieson BD, Zack JA, Picker LJ, Koup RA. (1998). Changes in thymic function with age and during the treatment of HIV infection. Nature. 396: 690-695.
18. Drakesmith H, Chen N, Ledermann H, Screaton G, Townsend A, Xu XN. (2005). HIV-1 Nef down regulates the hemochromatosis protein HFE, manipulating cellular iron homeostasis. Proceedings of the National Academy of Sciences USA. 102: 11017-11022.
19. Duus KM, Miller ED, Smith JA, Kovalev GI, Su L. (2001). Separation of human immunodeficiency virus type 1 replication from nef-mediated pathogenesis in the human thymus. Journal of Virology. 75: 3916-3924.
20. Dyer WB, Geczy AF, Kent SJ, McIntyre LB, Blasdall SA, Learmont JC, Sullivan JS. (1997). Lymphoproliferative immune function in the Sydney Blood Bank Cohort, infected with natural nef/long terminal repeat mutants, and in other long-term survivors of transfasion-acquired HIV-1 infection. AIDS. 11: 1565-1574.
21. Fackler OT, Baur AS. (2002). Live and let die: Nef functions beyond HIV replication. Immunity. 16: 493-497.
22. Fackler OT, Luo W, Geyer M, Alberts AS, Peterlin BM. (1999). Activation of Vav by Nef induces cytoskeletal rearrangements and downstream effector functions. Molecular Cell. 3: 729-739.
23. Garber ME, Wei P, KewalRamani VN, Mayall TP, Herrmann CH, Rice AP, Littman DR, Jones KA. (1998). The interaction between HIV-1 Tat and human cyclin T1 requires zinc and a critical cysteine residue that is not conserved in the murine CycT1 protein. Genes & Development. 12: 3512-3527.
24. Garcia JV, Miller AD. (1991). Serine phosphorylation-independent downregulation of cell-surface CD4 by nef. Nature. 350: 508-511.
25. Gaulton GN, Scobie JV, Rosenzweig M. (1997). HIV-1 and the thymus. Aids. 11: 403-414.
26. Geleziunas R, Xu W, Takeda K, Ichijo H, Greene WC. (2001). HIV-1 Nef inhibits ASK1-dependent death signalling providing a potential mechanism for protecting the infected host cell. Nature. 410: 834-838.
27. Genini D, Sheeter D, Rought S, Zaunders JJ, Susin SA, Kroemer G, Richman DD, Carson DA, Corbeil J, Leoni LM. (2001). HIV induces lymphocyte apoptosis by a p53-initiated, mitochondrial-mediated mechanism. FASEB Journal. 15: 5-6.
28. Greenway A, Azad A, McPhee D. (1995). Human immunodeficiency virus type 1 Nef protein inhibits activation pathways in peripheral blood mononuclear cells and T-cell lines. Journal of Virology. 69: 1842-1850.
29. Greenway AL, McPhee DA, Allen K, Johnstone R, Holloway G, Mills J, Azad A, Sankovich S, Lambert P. (2002). Human immunodeficiency virus type 1 Nef binds to tumor suppressor p53 and protects cells against p53-mediated apoptosis. Journal of Virology. 76: 2692-2702.
30. Gulizia RJ, Collman RG, Levy JA, Trono D, Mosier DE. (1997). Deletion of nef slows but does not prevent CD4-positive T-cell depletion in human immunodeficiency virus type 1-infected human-PBL-SCID mice. Journal of Virology. 71: 4161-4164.
31. Guy B, Kieny MP, Riviere Y, Le Peuch C, Dott K, Girard M, Montagnier L, Lecocq JP. (1987). HIV F/3′ orf encodes a phosphorylated GTP-binding protein resembling an oncogene product. Nature. 330: 266-269.
32. Hanna Z, Kay DG, Rebai N, Guimond A, Jothy S, Jolicoeur P. (1998). Nef harbors a major determinant of pathogenicity for an AIDS-like disease induced by HIV-1 in transgenic mice. Cell. 95: 163-175.
33. Hanna Z, Priceputu E, Kay DG, Poudrier J, Chrobak P, Jolicoeur P. (2004). In vivo mutational analysis of the N-terminal region of HIV-1 Nef reveals critical motifs for the development of an AIDS-like disease in CD4C/HIV transgenic mice. Virology. 327: 273-286.
34. Hanna Z, Weng X, Kay DG, Poudrier J, Lowell C, Jolicoeur P. (2001) The pathogenicity of human immunodeficiency virus (HIV) type 1 Nef in CD4C/ HIV transgenic mice is abolished by mutation of its SH3-binding domain, and disease development is delayed in the absence of Hck. Journal of Virology. 75: 9378-9392.
35. Hodge DR, Dunn KJ, Pei GK, Chakrabarty MK, Heidecker G, Lautenberger JA, Samuel KP. (1998). Binding of c-Rafl kinase to a conserved acidic sequence within the carboxyl-terminal region of the HIV-1 Nef protein. Journal of Biological Chemistry. 273: 15727-15733.
36. Jamieson BD, Aldrovandi GM, Planelles V, Jowett JB, Gao L, Bloch LM, Chen IS, Zack JA. (1994). Requirement of human immunodeficiency virus type 1 nef for in vivo replication and pathogenicity. Journal of Virology. 68: 3478-3485.
37. + cell depletion in human immunodeficiency virus type 1-infected SCID-hu mice suggest direct viral killing of thymocytes in vivo. Journal of Virology. 71: 8245-8253.
38. Jamieson BD, Zack JA. (1998). In vivo pathogenesis of a human immunodeficiency virus type 1 reporter virus. Journal of Virology. 72: 6520-6526.
39. Janardhan A, Swigut T, Hill B, Myers MP, Skowronski J. (2004). HIV-1 Nef binds the DOCK2-ELMO1 complex to activate rac and inhibit lymphocyte chemotaxis. PLoS Biology. 2: E6.
40. + T cells in vitro and in vivo. Journal of Virology. 71: 8456-8466.
41. Keppler OT, Allespach I, Schuller L, Fenard D, Greene WC, Fackler OT. (2005). Rodent cells support key functions of the human immunodeficiency virus type 1 pathogenicity factor Nef. Journal of Virology. 79: 1655-1665.
42. Kirchhoff F, Greenough TC, Brettler DB, Sullivan JL, Desrosiers RC. (1995). Brief report: absence of intact nef sequences in a long-term survivor with nonprogressive HIV-1 infection. The New England Journal of Medicine. 332: 228-232.
43. Lama J, Mangasarian A, Trono D. (1999). Cell-surface expression of CD4 reduces HIV-1 infectivity by blocking Env incorporation in a Nef- and Vpu-inhibitable manner. Current Biology. 9: 622-631.
44. Le Gall S, Erdtmann L, Benichou S, Berlioz-Torrent C, Liu L, Benarous R, Heard JM, Schwartz O. (1998). Nef interacts with the mu subunit of clathrin adaptor complexes and reveals a cryptic sorting signal in MHC I molecules. Immunity. 8: 483-495.
45. Lindemann D, Wilhelm R, Renard P, Althage A, Zinkernagel R, Mous J. (1994). Severe immunodeficiency associated with a human immunodeficiency virus 1 NEF/3′-long terminal repeat transgene. Journal of Experimental Medicine. 179: 797-807.
46. Manninen A, Saksela K. (2002). HIV-1 Nef interacts with inositol trisphosphate receptor to activate calcium signaling in T cells. Journal of Experimental Medicine. 195: 1023-1032.
47. Mariani R, Chen D, Schrofelbauer B, Navarro F, Konig R, Bollman B, Munk C, Nymark-McMahon H, Landau NR. (2003). Species-specific exclusion of APOBEC3G from HIV-1 virions by Vif. Cell. 114: 21-31.
48. Michel N, Allespach I, Venzke S, Fackler OT, Keppler OT. (2005). The Nef protein of human immunodeficiency virus establishes superinfection immunity by a dual strategy to downregulate cell-surface CCR5 and CD4. Current Biology. 15: 714-723.
49. Namikawa R, Weilbaecher KN, Kaneshima H, Yee EJ, McCune JM. (1990). Long-term human hematopoiesis in the SCID-hu mouse. Journal of Experimental Medicine. 172: 1055-1063.
50. Renkema GH, Manninen A, Mann DA, Harris M, Saksela K. (1999). Identification of the Nef-associated kinase as p21-activated kinase 2. Current Biology. 9: 1407-1410.
51. Rhee SS, Marsh JW. (1994). Human immunodeficiency virus type 1 Nef-induced down modulation of CD4 is due to rapid internalization and degradation of surface CD4. Journal of Virology. 68: 5156-5163.
52. Robert-Guroff M, Popovic M, Gartner S, Markham P, Gallo RC, Reitz MS. (1990). Structure and expression of tat-, rev-, and nef- specific transcripts of human immunodeficiency virus type 1 in infected lymphocytes and macrophages. Journal of Virology. 64: 3391-3398.
53. Rosenzweig M, Clark DP, Gaulton GN. (1993). Selective thymocyte depletion in neonatal HIV-1 thymic infection. Aids. 7: 1601-1605.
54. Ross TM, Oran AE, Cullen BR. (1999). Inhibition of HIV-1 progeny virion release by cell-surface CD4 is relieved by expression of the viral Nef protein. Current Biology. 9: 613-621.
55. Saksela K, Cheng G, Baltimore D. (1995). Proline-rich (PxxP) motifs in HIV-1 Nef bind to SH3 domains of a subset of Src kinases and are required for the enhanced growth of Nef+ viruses but not for down regulation of CD4. The EMBO Journal. 14: 484-491.
56. Schindler M, Munch J, Kirchhoff F. (2005). Human immunodeficiency virus type 1 inhibits DNA damage-triggered apoptosis by a Nef-independent mechanism. Journal of Virology. 79: 5489-5498.
57. + (T4) lymphocyte depletion. Proc Natl Acad Sci USA. 87: 7727-7731.
58. Schrager JA, Marsh JW. (1999). HIV-1 Nef increases T cell activation in a stimulus-dependent manner. Proceedings of the National Academy of Sciences USA. 96: 8167-8172.
59. Schwartz O, Marechal V, Le Gall S, Lemonnier F, Heard JM. (1996). Endocytosis of major histocompatibility complex class I molecules is induced by the HIV-1 Nef protein. Nature Medicine. 2: 338-342.
60. Shinya E, Owaki A, Shimizu M, Takeuchi J, Kawashima T, Hidaka C, Satomi M, Watari E, Sugita M, Takahashi H. (2004). Endogenously expressed HIV-1 nef down regulates antigen-presenting molecules, not only class I MHC but also CD1a, in immature dendritic cells. Virology. 326: 79-89.
61. Simmons A, Aluvihare V, McMichael A. (2001). Nef triggers a transcriptional program in T cells imitating single-signal T cell activation and inducing HIV virulence mediators. Immunity. 14: 763-777.
62. Skowronski J, Parks D, Mariani R. (1993). Altered T cell activation and development in transgenic mice expressing the HIV-1 nef gene. The EMBO Journal. 12: 703-713.
63. Smith BL, Krushelnycky BW, Mochly-Rosen D, Berg P. (1996). The HIV nef protein associates with protein kinase C theta. Journal of Biological Chemistry. 271: 16753-16757.
64. Sol-Foulon N, Moris A, Nobile C, Boccaccio C, Engering A, Abastado JP, Heard JM, van Kooyk Y, Schwartz O. (2002). HIV-1 Nef-induced upregulation of DC-SIGN in dendritic cells promotes lymphocyte clustering and viral spread. Immunity. 16: 145-155.
65. Stebbing J, Gazzard B, Douek DC. (2004). Where does HIV live? The New England Journal of Medicine. 350: 1872-1880.
66. Stoddart CA, Geleziunas R, Ferrell S, Linquist-Stepps V, Morena ME, Bare C, Xu W, Yonemoto W, Bresnahan PA, McCune JM, Greene WC. (2003). Human Immunodeficiency Virus type 1 Nef-mediated downregulation of CD4 correlates with Nef enhancement of viral pathogenesis. Journal of Virology. 77: 2124-2133.
67. Stove V, Naessens E, Stove C, Swigut T, Plum J, Verhasselt B. (2003). Signaling but not trafficking function of HIV-1 protein Nef is essential for Nef-induced defects in human intrathymic T-cell development. Blood. 102: 2925-2932.
68. Stove V, Van de Walle I, Naessens E, Coene E, Stove C, Plum J, Verhasselt B. (2005). Human Immunodeficiency Virus Nef Induces Rapid Internalization of the T-Cell Coreceptor CD8alphabeta. Journal of Virology. 79: 11422-11433.
69. Stumptner-Cuvelette P, Morchoisne S, Dugast M, Le Gall S, Raposo G, Schwartz O, Benaroch P. (2001). HIV-1 Nef impairs MHC class II antigen presentation and surface expression. Proceedings of the National Academy of Sciences USA. 98: 12144-12149.
70. Su L, Kaneshima H, Bonyhadi M, Salimi S, Kraft D, Rabin L, McCune JM. (1995). HIV-1-induced thymocyte depletion is associated with indirect cytopathogenicity and infection of progenitor cells in vivo. Immunity. 2: 25-36.
71. Swigut T, Shohdy N, Skowronski J. (2001). Mechanism for down regulation of CD28 by Nef. The EMBO Journal. 20: 1593-1604.
72. Torbett BE, Picchio G, Mosier DE. (1991). hu-PBL-SCID mice: a model for human immune function, AIDS, and lymphomagenesis. Immunology Reviews 124: 139-164.
73. Valentin H, Nugeyre MT, Vuillier F, Boumsell L, Schmid M, Barre Sinoussi F, Pereira RA. (1994). Two subpopulations of human triple-negative thymic cells are susceptible to infection by human immunodeficiency virus type 1 in vitro. Journal of Virology. 68: 3041-3050.
74. Verhasselt B, Naessens E, Verhofstede C, De Smedt M, Schollen S, Kerre T, Vanhecke D, Plum J. (1999). Human immunodeficiency virus nef gene expression affects generation and function of human T cells, but not dendritic cells. Blood. 94: 2809-2818.
75. Vigerust DJ, Egan BS, Shepherd VL. (2005). HIV-1 Nef mediates post-translational down regulation and redistribution of the mannose receptor. Journal of Leukocyte Biology. 77: 522-534.
76. Wei BL, Arora VK, Foster JL, Sodora DL, Garcia JV. (2003). In vivo analysis of Nef function. Current HIV Research. 41-50.
77. + T cells from CD4C/HIVNef transgenic mice show enhanced activation in vivo with impaired proliferation in vitro but are dispensable for the development of a severe AIDS-like organ disease. Journal of Virology. 78: 5244-5257.
78. Williams M, Roeth JF, Kasper MR, Fleis RI, Przybycin CG, Collins KL. (2002). Direct binding of human immunodeficiency virus type 1 Nef to the major histocompatibility complex class I (MHC-I) cytoplasmic tail disrupts MHC-I trafficking. Journal of Virology. 76: 12173-12184.
79. Witte V, Laffert B, Rosorius O, Lischka P, Blume K, Galler G, Stilper A, Willbold D, D'Aloja P, Sixt M, Kolanus J, Ott M, Kolanus W, Schuler G, Baur AS. (2004). HIV-1 Nef mimics an integrin receptor signal that recruits the polycomb group protein Eed to the plasma membrane. Molecular Cell. 13: 179-190.
80. Wolf D, Witte V, Laffert B, Blume K, Stromer E, Trapp S, d'Aloja P, Schurmann A, Baur AS. (2001). HIV-1 Nef associated PAK and P13-Kinases stimulate Akt-independent Bad-phosphorylation to induce anti-apoptotic signals. Nature Medicine. 7: 1217-1224.
81. Xu X-N, Laffert B, Screaton GR, Kraft M, Wolf D, Kolanus W, Mongkolsapay J, McMichael AJ, Baur AS. (1999). Induction of Fas ligand expression by HIV involves the interaction of Nef with the T cell receptor zeta chain. Journal of Experimental Medicine. 189: 1489-1496.
82. Ye P, Kirschner DE, Kourtis AP. (2004). The thymus during HIV disease: role in pathogenesis and in immune recovery. Current HIV Research. 2: 177-183.
83. Zheng YH, Yu HF, Peterlin BM. (2003). Human p32 protein relieves a post-transcriptional block to HIV replication in murine cells. Nature Cell Biolology. 5: 611-618.